Revealing a New Hope

ASCO 2023: Game-Changing Results Unveiled: Zanidatamab Shows Promise in HER2-Amplified Biliary Tract Cancers, Revealing a New Hope

ASCO 2023: Zanidatamab – A New Hope for HER2-Amplified Biliary Tract Cancers

SG Tylor

ABSTRACT NUMBER – 4008 A subset of biliary tract cancer cases presents either with overexpression or amplification of the HER2 ...